Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11993771 Methods and compositions for cell-free cloning

Patent 11993771 was granted and assigned to Elegen on May, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Elegen
Elegen
0
Date Filed
June 16, 2023
0
Date of Patent
May 28, 2024
0
Patent Applicant
Elegen
Elegen
0
Patent Application Number
18336283
0
Patent Citations
‌
US Patent 10632445 De novo synthesized gene libraries
0
‌
US Patent 10773232 De novo synthesized gene libraries
0
‌
US Patent 7164992 Method and system for polynucleotide synthesis
0
‌
US Patent 8137906 Method for the synthesis of DNA fragments
0
‌
US Patent 9839894 De novo synthesized gene libraries
0
‌
US Patent 10301672 Method of amplifying circular DNA
0
‌
US Patent 10504615 Using cancer or pre-cancer subject sequencing data and a database of therapy biomarker distributions to determine normalized biomarker scores and generate a graphical user interface
0
Patent Inventor Names
Matthew Hill
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11993771
0
Patent Primary Examiner
‌
Aaron A Priest
0
CPC Code
‌
C12N 15/1065
0

Find more entities like US Patent 11993771 Methods and compositions for cell-free cloning

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.